A detailed history of Deutsche Bank Ag\ transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 138,669 shares of EBS stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
138,669
Previous 138,669 -0.0%
Holding current value
$1.17 Million
Previous $945,000 22.43%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.86 - $6.98 $38,598 - $144,848
-20,752 Reduced 13.02%
138,669 $945,000
Q1 2024

May 15, 2024

SELL
$1.5 - $3.41 $1,566 - $3,560
-1,044 Reduced 0.65%
159,421 $403,000
Q4 2023

Feb 14, 2024

BUY
$1.82 - $3.16 $247,893 - $430,407
136,205 Added 561.44%
160,465 $385,000
Q3 2023

Nov 09, 2023

SELL
$3.17 - $7.91 $763,982 - $1.91 Million
-241,004 Reduced 90.85%
24,260 $82,000
Q2 2023

Aug 14, 2023

SELL
$7.35 - $13.21 $97,181 - $174,662
-13,222 Reduced 4.75%
265,264 $1.95 Million
Q1 2023

May 15, 2023

BUY
$7.79 - $16.29 $40,313 - $84,300
5,175 Added 1.89%
278,486 $2.89 Million
Q4 2022

Feb 13, 2023

SELL
$11.0 - $21.45 $1.38 Million - $2.69 Million
-125,282 Reduced 31.43%
273,311 $3.23 Million
Q3 2022

Nov 14, 2022

SELL
$20.09 - $35.8 $99,144 - $176,673
-4,935 Reduced 1.22%
398,593 $8.37 Million
Q2 2022

Aug 11, 2022

BUY
$27.42 - $43.63 $617,717 - $982,896
22,528 Added 5.91%
403,528 $12.5 Million
Q1 2022

May 13, 2022

BUY
$36.48 - $52.22 $8.87 Million - $12.7 Million
243,115 Added 176.32%
381,000 $15.6 Million
Q4 2021

Feb 11, 2022

BUY
$33.11 - $55.01 $182,138 - $302,610
5,501 Added 4.16%
137,885 $5.99 Million
Q3 2021

Nov 04, 2021

SELL
$50.07 - $66.05 $39,304 - $51,849
-785 Reduced 0.59%
132,384 $6.63 Million
Q2 2021

Aug 11, 2021

SELL
$56.61 - $80.46 $3.25 Million - $4.62 Million
-57,435 Reduced 30.13%
133,169 $8.39 Million
Q1 2021

May 13, 2021

SELL
$86.23 - $125.19 $4.12 Million - $5.98 Million
-47,788 Reduced 20.05%
190,604 $17.7 Million
Q4 2020

Feb 16, 2021

BUY
$79.17 - $111.47 $4.34 Million - $6.1 Million
54,759 Added 29.82%
238,392 $21.4 Million
Q3 2020

Nov 12, 2020

SELL
$81.91 - $134.94 $2.63 Million - $4.33 Million
-32,101 Reduced 14.88%
183,633 $19 Million
Q2 2020

Aug 13, 2020

SELL
$54.33 - $89.52 $575,952 - $949,001
-10,601 Reduced 4.68%
215,734 $17.1 Million
Q1 2020

May 14, 2020

SELL
$49.34 - $68.76 $1.19 Million - $1.66 Million
-24,185 Reduced 9.65%
226,335 $13.1 Million
Q4 2019

Feb 14, 2020

BUY
$51.21 - $59.06 $3.54 Million - $4.08 Million
69,143 Added 38.12%
250,520 $13.5 Million
Q3 2019

Nov 14, 2019

BUY
$40.6 - $57.2 $2.52 Million - $3.55 Million
62,138 Added 52.11%
181,377 $9.48 Million
Q2 2019

Aug 14, 2019

SELL
$39.92 - $53.86 $5.3 Million - $7.14 Million
-132,649 Reduced 52.66%
119,239 $5.76 Million
Q1 2019

May 15, 2019

BUY
$48.23 - $66.16 $7.38 Million - $10.1 Million
152,914 Added 154.5%
251,888 $12.7 Million
Q4 2018

Feb 14, 2019

SELL
$55.63 - $73.24 $11.6 Million - $15.3 Million
-209,199 Reduced 67.88%
98,974 $5.87 Million
Q3 2018

Dec 21, 2021

BUY
$52.05 - $66.51 $9.86 Million - $12.6 Million
189,386 Added 159.43%
308,173 $20.3 Million
Q3 2018

Nov 14, 2018

SELL
$52.05 - $66.51 $10.6 Million - $13.6 Million
-203,960 Reduced 63.2%
118,787 $7.82 Million
Q2 2018

Apr 21, 2020

BUY
$48.33 - $55.64 $6.89 Million - $7.93 Million
142,580 Added 79.14%
322,747 $16.3 Million
Q2 2018

Aug 14, 2018

SELL
$48.33 - $55.64 $8.96 Million - $10.3 Million
-185,440 Reduced 50.72%
180,167 $9.09 Million
Q1 2018

Oct 18, 2019

BUY
$44.44 - $54.39 $5.76 Million - $7.04 Million
129,511 Added 54.86%
365,607 $19.2 Million
Q1 2018

May 15, 2018

SELL
$44.44 - $54.39 $795,698 - $973,852
-17,905 Reduced 7.05%
236,096 $12.4 Million
Q4 2017

Feb 14, 2018

BUY
$37.77 - $47.75 $3.11 Million - $3.94 Million
82,454 Added 48.06%
254,001 $11.8 Million
Q3 2017

Nov 14, 2017

BUY
$34.14 - $40.45 $5.86 Million - $6.94 Million
171,547
171,547 $6.94 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $420M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.